APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry Feb 17, 2018
Liu CC, et al. - Researchers here sought to report an association of the genetic variants in the APBB2gene with use of amphetamine in opioid-dependent patients undergoing methadone maintenance treatment (MMT). In the urine morphine test, a significantly higher percentage of positive results were observed among MMT patients who used amphetamine. Findings suggested that APBB2gene was associated with use of amphetamine among opioid dependent patients under MMT. A positive correlation was revealed between Single nucleotide polymorphism (SNP) rs4861075 and the severity of amphetamine use. In the urine morphine test negative patients, SNP rs78704328 was associated with plasma level of Aβ42 and Aβ42/Aβ40 ratio.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries